Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.
2.
3.

Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin-tazobactam.

Solano C, Gutierrez A, Martinez F, Gimeno C, Gómez C, Muñoz I, Faus F, Goterris R, Farga A, Navarro D.

Bone Marrow Transplant. 2005 Jul;36(1):59-65.

PMID:
15908979
4.
5.

Febrile neutropenic infection occurred in cancer patients undergoing autologous peripheral blood stem cell transplantation.

Zhang WX, Zhao QY, Huang HQ.

Transplant Proc. 2015 Mar;47(2):523-7. doi: 10.1016/j.transproceed.2015.01.013.

PMID:
25769601
6.

Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infections.

Gallis HA, Brennan RO, Goodwin SD, Swinney V, Rumbaugh MM, Drew RH.

Am J Med. 1989 Nov 30;87(5A):176S-180S.

PMID:
2686418
8.

A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.

Metallidis S, Kollaras P, Giannakakis T, Seitanidis B, Kordosis T, Nikolaidis J, Hatzitolios A, Nikolaidis P.

Eur J Intern Med. 2008 Dec;19(8):619-24. doi: 10.1016/j.ejim.2007.08.011. Epub 2008 Apr 29.

PMID:
19046729
9.

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.

Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J, et al.

N Engl J Med. 1986 Aug 28;315(9):552-8.

PMID:
3526155
10.

Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.

Kim JH, Goulston C, Zangari M, Tricot G, Boyer MW, Hanson KE.

Transpl Infect Dis. 2014 Jun;16(3):421-9. doi: 10.1111/tid.12225. Epub 2014 May 5.

PMID:
24797543
11.

Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation.

Egerer G, Goldschmidt H, Hensel M, Harter C, Schneeweiss A, Ehrhard I, Bastert G, Ho AD.

Bone Marrow Transplant. 2002 Oct;30(7):427-31.

12.
13.
14.

Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.

Mustafa MM, Carlson L, Tkaczewski I, McCracken GH Jr, Buchanan GR.

Pediatr Infect Dis J. 2001 Mar;20(3):362-9. Review.

PMID:
11303851
15.
16.

Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial.

Vehreschild JJ, Moritz G, Vehreschild MJ, Arenz D, Mahne M, Bredenfeld H, Chemnitz J, Klein F, Cremer B, Böll B, Kaul I, Wassmer G, Hallek M, Scheid C, Cornely OA.

Int J Antimicrob Agents. 2012 Feb;39(2):130-4. doi: 10.1016/j.ijantimicag.2011.10.009. Epub 2011 Dec 12.

PMID:
22169408
17.
18.

[A clinical analysis of early stage infection after auto peripheral blood stem cell transplantation].

Duan MH, Zhou DB, Wang SJ, Han B, Zhao YQ, Shen T.

Zhonghua Nei Ke Za Zhi. 2007 Jan;46(1):32-4. Chinese.

PMID:
17331386
19.

Prospective study of empiric monotherapy with ceftazidime for low-risk grade IV febrile neutropenia after cytotoxic chemotherapy in cancer patients.

Chernobelski P, Lavrenkov K, Rimar D, Riesenberg K, Schlaeffer F, Ariad S, Mermershtain W.

Chemotherapy. 2006;52(4):185-9. Epub 2006 May 2.

PMID:
16675902
20.

Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation.

Egerer G, Goldschmidt H, Salwender H, Hegenbart U, Ehrhard I, Haas R, Ho AD.

Int J Antimicrob Agents. 2000 Jul;15(2):119-23.

PMID:
10854807

Supplemental Content

Support Center